CA2701721C - Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid - Google Patents

Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid Download PDF

Info

Publication number
CA2701721C
CA2701721C CA2701721A CA2701721A CA2701721C CA 2701721 C CA2701721 C CA 2701721C CA 2701721 A CA2701721 A CA 2701721A CA 2701721 A CA2701721 A CA 2701721A CA 2701721 C CA2701721 C CA 2701721C
Authority
CA
Canada
Prior art keywords
tsp
hyaluronic acid
weight
tamarind seed
seed polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2701721A
Other languages
English (en)
French (fr)
Other versions
CA2701721A1 (en
Inventor
Antonio Del Prete
Marco Sanso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ITH Srl
Original Assignee
RMFA Trading SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RMFA Trading SA filed Critical RMFA Trading SA
Publication of CA2701721A1 publication Critical patent/CA2701721A1/en
Application granted granted Critical
Publication of CA2701721C publication Critical patent/CA2701721C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2701721A 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid Active CA2701721C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2007A000510 2007-10-02
IT000510A ITRM20070510A1 (it) 2007-10-02 2007-10-02 Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
PCT/IT2008/000626 WO2009044423A1 (en) 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid

Publications (2)

Publication Number Publication Date
CA2701721A1 CA2701721A1 (en) 2009-04-09
CA2701721C true CA2701721C (en) 2016-02-23

Family

ID=40314052

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2701721A Active CA2701721C (en) 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid

Country Status (14)

Country Link
US (1) US8455462B2 (enExample)
EP (1) EP2197456B1 (enExample)
JP (1) JP5542674B2 (enExample)
KR (1) KR101570966B1 (enExample)
AT (1) ATE499106T1 (enExample)
CA (1) CA2701721C (enExample)
DE (1) DE602008005173D1 (enExample)
ES (1) ES2361529T3 (enExample)
IT (1) ITRM20070510A1 (enExample)
MX (1) MX2010003488A (enExample)
PL (1) PL2197456T3 (enExample)
PT (1) PT2197456E (enExample)
RU (1) RU2493855C2 (enExample)
WO (1) WO2009044423A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1861069B2 (en) * 2005-02-09 2013-07-03 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
IT1396607B1 (it) 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
EP2575973B1 (en) 2010-05-24 2017-06-28 Indena S.p.A. Tamarind seed polysaccharide and ferula hermonis extract for use in the treatment of inflammatory diseases
EP2575971B1 (en) * 2010-05-24 2015-12-16 Indena S.p.A. Combined plant extracts for use in the treatment of microbial infections
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
EP3348273B8 (en) 2014-04-15 2019-09-18 Devintec, Sagl Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
ES2705692T3 (es) 2015-06-11 2019-03-26 Novintethical Pharma Sa Composiciones nasales tópicas que contienen xiloglucanos para usar como descongestionantes
CN108135956B (zh) * 2015-07-13 2021-06-08 东北泰克诺亚奇股份有限公司 视神经保护用组合物
AR108280A1 (es) * 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) * 2016-10-27 2018-04-27 Giuliani Spa Composizioni dermatologiche
US10702578B2 (en) * 2017-08-02 2020-07-07 Shilpa Medicare Limited Ophthalmic compositions of cyclosporine
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
IL280109B2 (en) * 2018-07-18 2024-08-01 Atg 20 S R L Preparations containing glycyrrhizin and their cosmetic and medical uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
DE69833000T2 (de) * 1997-09-26 2006-09-07 Noven Pharmaceuticals, Inc., Miami Bio-klebemittelzusammensetzungen
CZ20012038A3 (cs) * 1998-12-23 2001-09-12 Idea Ag Zdokonalený přípravek pro topické, neinvazivní použití in vivo
EP1667705A1 (en) * 2003-10-03 2006-06-14 Allergan, Inc. Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
EP1861069B2 (en) 2005-02-09 2013-07-03 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
TWI393567B (zh) * 2005-03-31 2013-04-21 博士倫公司 治療乾眼之組合物及相關之製造方法及使用方法

Also Published As

Publication number Publication date
US8455462B2 (en) 2013-06-04
KR101570966B1 (ko) 2015-11-23
US20100279981A1 (en) 2010-11-04
EP2197456B1 (en) 2011-02-23
CA2701721A1 (en) 2009-04-09
MX2010003488A (es) 2010-08-31
JP5542674B2 (ja) 2014-07-09
PL2197456T3 (pl) 2012-07-31
PT2197456E (pt) 2011-05-18
JP2010540619A (ja) 2010-12-24
WO2009044423A1 (en) 2009-04-09
ITRM20070510A1 (it) 2009-04-03
ES2361529T3 (es) 2011-06-17
EP2197456A1 (en) 2010-06-23
KR20100091151A (ko) 2010-08-18
RU2493855C2 (ru) 2013-09-27
ATE499106T1 (de) 2011-03-15
RU2010117173A (ru) 2011-11-10
DE602008005173D1 (de) 2011-04-07

Similar Documents

Publication Publication Date Title
EP2197456B1 (en) Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid
EP0892636B1 (en) Ophthalmic solutions viscosified with tamarind seed polysaccharide
RU2663449C2 (ru) Глазные композиции, содержащие мукоадгезивные полисахариды, способные стимулировать восстановление эпителия роговицы
DE10161149B4 (de) Verwendung von Heparin-haltigem Ophthalmikum
DE60205913T2 (de) Ophthalmische zubereitung mit n-acetylcystein zur behandlung trockener augen
KR20230019108A (ko) 안구건조증 치료용 마이크로에멀젼
CN111050777B (zh) 提供改善的眼睛舒适度的组合物
Singh Review of various lacrimomimetics: making the appropriate choice
JP2019514887A (ja) グリコーゲンとヒアルロン酸またはその塩との相乗的組み合わせを含む眼科用組成物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130906

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240827

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240827

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240827

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R11-R127 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER RECORDAL REQUEST OR RESPONSE

Effective date: 20241212

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241212

R14 Transfer of ownership recorded

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R14-R129 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250510

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250826

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250826

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260728